Smartlab Europe

News

CluePoints Wins Best Risk-Based Monitoring Solution in 2018 Biotechnology Awards

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has been honoured in this year’s Biotechnology Awards with the CluePoints® solution being named the “Best Risk-Based Monitoring Solution”. The...

Data Integrity, Business and Process Efficiencies Take Center Stage as CRF Health Appoints New Vice President of Quality Assurance

CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has announced the appointment of former Novartis veteran and eClinical Quality Assurance and Data Integrity Specialist, Tom Haag, as Vice President,...

Sterling Pharma Solutions expands presence in Japan

Global API developer and manufacturer, Sterling Pharma Solutions, has experienced growth in the Japanese market as a result of its technical capabilities and innovation strategy. The contract development and manufacturing organisation (CDMO) now works with a...

MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced completion of a pre-planned interim futility analysis of the Phase 3 SOPHIA trial. This...

POREX® Showcases New Innovations in Diagnostics, Liquid Handling and Wound Management at MD&M West 2018

Porex Corporation will showcase advanced solutions for laboratory and medical professionals that speed fluid transfer of diagnostics, improve accuracy and purity in liquid handling, and enhance wound management and improve clinical outcomes.  These innovations, offering new...

Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication

Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential...

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »